Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 28, 2015 3:50 PM ET

Healthcare Equipment and Supplies

Company Overview of ZOLL Medical Corporation

Company Overview

ZOLL Medical Corporation develops, manufactures, and markets resuscitation devices, related data management and software solutions, and temperature management technology worldwide. The company provides technologies that help clinicians, EMS and fire professionals, and lay rescuers in treating victims needing resuscitation and critical care. It offers lifevest wearable defibrillators for various indications comprising heart attack, before or after bypass surgery, or stent placement; patients with cardiomyopathy or congestive heart failures; and patients awaiting an implantable defibrillator or after removal of an implantable device due to infection or other reasons, as well as AutoPulse, an a...

269 Mill Road

Chelmsford, MA 01824

United States

Founded in 1980

1,908 Employees

Phone:

978-421-9655

Fax:

978-421-0025

Key Executives for ZOLL Medical Corporation

Chief Executive Officer and Executive Director
Age: 56
President of ZOLL Data Management Products
Age: 50
President of ZOLL Core Products
Age: 50
Chief Operating Officer of ZOLL LifeVest and President of ZOLL LifeVest
President of Circulation
Compensation as of Fiscal Year 2014.

ZOLL Medical Corporation Key Developments

ZOLL®Medical Corporation's ResQCPR System Receives Premarket Approval from FDA

ZOLL®Medical Corporation announced that the company’s ResQCPR System has been granted premarket approval (PMA) by the U.S. Food and Drug Administration (FDA) to market and begin U.S. distribution of the CPR adjunct system. The technology, which has been shown to improve the likelihood of survival in adult patients with non-traumatic cardiac arrest, is expected to be commercially available in mid-2015. A pivotal study evaluating the ResQCPR System, known as the ResQTRIAL, which the FDA considered in its approval process, demonstrated a 49% increase in survival to one year in adult patients who experienced out-of-hospital cardiac arrest of presumed cardiac etiology, as compared to treatment with conventional manual CPR. If widely implemented, the ResQCPR System could save thousands of lives each year in the U.S. from out-of-hospital cardiac arrest alone, based on these study results. The ResQCPR System uses Intrathoracic Pressure Regulation (IPR), a proprietary, non-invasive therapy developed by Advanced Circulatory Systems Inc. of Roseville, Minn., which ZOLL acquired in January 2015. This innovative technology uses the body’s own mechanisms to enhance circulation without the use of pharmaceutical or other agents. The ResQCPR System is comprised of the ResQPOD® Impedance Threshold Device and the ResQPUMP® Active Compression-Decompression CPR Device, which work synergistically to improve perfusion.

ZOLL Medical Corporation Wins $39.85 Million Federal Contract Award

ZOLL Medical Corporation was awarded a $39,848,375 federal contract by the Defense Logistics Agency Troop Support, Philadelphia, for access to airworthy defibrillators inventory for the U.S. Army, U.S. Navy, U.S. Air Force, U.S. Marine Corps and federal civilian agencies.

Jersey City Medical Center Uses ZOLL Medical Corporation's Driver Behavior Modification Technology to Prevent Ambulance Crashes and Improve Safety for the Community

Jersey City Medical Center EMS announced that to mitigate safety risks, JCMS EMS has deployed on-board safety technology that modifies driver behavior and provides real-time feedback alerting the drivers of dangerous driving habits. The goal is to instill a culture of safety among staff and the community, reducing the likelihood of a crash. The Road Safety(R) system from ZOLL Medical Corporation--much like an electronic co-pilot--measures multiple inputs including speed, braking, and G Forces on turns. If a driver, for example, is applying brakes too harshly, taking turns too severely, or exceeding pre-determined speed limits, audible tones will alert the driver to take corrective action.

Similar Private Companies By Industry

Company Name Region
Vital 5 United States
Harry J. Bosworth Company United States
Spineology Inc. United States
DC Devices Inc. United States
Kinex Medical Company, LLC United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
December 22, 2014
Advanced Circulatory Systems, Inc.
Merger/Acquisition
November 17, 2014
Post-Hypothermia Corporation
Merger/Acquisition
October 28, 2014
Impact Instrumentation Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZOLL Medical Corporation, please visit www.zoll.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.